An analysis of the emerging patent landscape of gene therapies under development, focusing on non-viral vectors.
References
Raper, S. E. et al. Mol. Genet. Metab. 80, 148–158 (2003).
Kim, T. K. & Eberwine, J. H. Anal. Bioanal. Chem. 397, 3821–3826 (2010).
Garçon, L. et al. Blood 122, 912–921 (2013).
de Sousa Russo-Carbolante, E. M. et al. Biotechnol. Lett. 33, 23–31 (2010).
Michieletto, D., Lusic, M., Marenduzzo, D. & Orlandini, E. Nat. Commun. 10, 575 (2019).
Atianand, M. K. & Fitzgerald, K. A. J. Immunol. 190, 1911–1918 (2013).
Tao, J., Zhou, X. & Jiang, Z. IUBMB Life 68, 858–870 (2016).
Gándara, C., Affleck, V. & Stoll, E. A. Hum. Gene Ther. Methods https://doi.org/10.1089/hgtb.2017.098 (published online 1 February 2018).
Jenke, A. C. W. et al. Proc. Natl. Acad. Sci. USA 101, 11322–11327 (2004).
Stavrou, E. F. et al. Sci. Rep. 7, 40673 (2017).
Hagedorn, C., Antoniou, M. N. & Lipps, H. J. Mol. Ther. Nucleic Acids 3, e118 (2013).
Saunders, F., Sweeney, B., Antoniou, M. N., Stephens, P. & Cain, K. PLoS One 10, (e0120096 (2015).
Haase, R. et al. BMC Biotechnol. 10, 20 (2010).
Acknowledgements
We acknowledge support from the Basic Medical Sciences Department at the Purdue University School of Veterinary Medicine, Purdue Center for Cancer Research, and the Purdue Institute for Drug Discovery. This work was supported in part by NIH grants R01CA196947 and R01AR069079 and FAPESP grants 2017/25364-6, 2013/08135-2 and 2014/22500-8.
Author information
Authors and Affiliations
Contributions
V.P.C., C.G.P., G.S.P. and M.L.F. designed the experiments, analyzed the data and wrote the manuscript; A.A. and D.C. discussed the data and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Picanço-Castro, V., Pereira, C.G., Covas, D.T. et al. Emerging patent landscape for non-viral vectors used for gene therapy. Nat Biotechnol 38, 151–157 (2020). https://doi.org/10.1038/s41587-019-0402-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-019-0402-x
- Springer Nature America, Inc.
This article is cited by
-
Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy
Drug Delivery and Translational Research (2023)
-
Progress in Intradermal and Transdermal Gene Therapy with Microneedles
Pharmaceutical Research (2022)
-
Oxygen nanocarrier broke the hypoxia trap of solid tumors and rescued transfection efficiency for gene therapy
Journal of Nanobiotechnology (2021)